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Extended-spectrum cephalosporin-resistant Salmonella en-
terica serovar Heidelberg strains (JF6X01.0022/XbaI.0251, 
JF6X01.0326/XbaI.1966, JF6X01.0258/XbaI.1968, and 
JF6X01.0045/XbaI.1970) have been identified in the United 
States with pulsed-field gel electrophoresis. Our examina-
tion of isolates showed introduction of these strains in the 
Netherlands and highlight the need for active surveillance 
and intervention strategies by public health organizations.
Salmonella enterica serovar Heidelberg is among the most prevalent causes of human salmonellosis in the 
United States and Canada but has been reported infre-
quently in Europe (1–3). Although most nontyphoidal 
Salmonella infections are self-limiting and resolve within 
a few days, Salmonella ser. Heidelberg tends to provoke 
invasive infections (e.g., myocarditis and bacteremia) that 
require antimicrobial drug therapy (4). To treat systemic 
nontyphoidal Salmonella infections, third-generation ceph-
alosporins are preferred drugs for children or for adults 
with fluoroquinolone contraindications (5). Resistance to 
third-generation cephalosporins is increasing in S. enterica 
infections, mainly because of production of plasmid-medi-
ated extended-spectrum or AmpC β-lactamases (6).
Resistance to extended-spectrum cephalosporins 
(ESCs) among Salmonella Heidelberg strains found in 
human infections, food-producing animals, and poultry 
meat indicates zoonotic and foodborne transmission of 
these strains and potential effects on public health (7,8). 
Unlike in Canada and the United States, few ESC-resis-
tant Salmonella Heidelberg strains have been document-
ed in Europe (9–13). However, increased occurrence of 
ESC resistance in S. enterica infections and decreased 
susceptibility to fluoroquinolones compromise the use 
of these drugs and constitute a serious public health 
threat (6,14).
Few data are available regarding prevalence of ESC-
resistant Salmonella Heidelberg isolates in Europe, their 
underlying antimicrobial drug resistance gene content, and 
genetic platforms (i.e., plasmids and insertion sequence [IS] 
elements) associated with resistance genes. We attempted 
to determine the occurrence and molecular characteristics 
of Salmonella Heidelberg isolates recovered from human 
patients, food-producing animals, and poultry meat in the 
Netherlands during 1999–2013.
The Study
During 1999–2013, the Netherlands National Institute of 
Public Health and the Environment collected 437 Salmo-
nella Heidelberg isolates from human infections (n = 77 
[17.6%]), food-producing animals (n = 138 [31.6%]), 
poultry meat (n = 170 [38.9%]), and other sources (n = 
52 [11.9%]). From this collection, we selected 200 epide-
miologically unrelated isolates for further analysis (Table; 
online Technical Appendix, http://wwwnc.cdc.gov/EID/
article/22/7/15-1377-Techapp.pdf).
MICs for antimicrobial agents were determined with 
the broth microdilution method (online Technical Appen-
dix) and showed a higher frequency of multidrug non–
wild-type susceptibility phenotype in isolates from poultry 
meat (n = 44 [68.8%]) than in isolates from food-produc-
ing animals (n = 14 [31.8%]) and human infections (n = 
16 [19.5%]). Most human infections exhibited wild-type 
MICs to most antimicrobial agents tested (Table).
Of the 200 Salmonella Heidelberg isolates in the study, 
47 (23.5%) were ESC resistant. ESC resistance in Salmo-
nella Heidelberg isolates increased from 33.3% in 2011 to 
60.0% in 2012 to 75.0% in 2013, after which Salmonella 
Heidelberg was the predominant serotype in ESC-resistant 
Salmonella isolates in the Netherlands (Figure 1).
These isolates showed MICs for cefotaxime and 
ceftazidime of 2 to >4 mg/L and 4 to >16 mg/L, respec-
tively; non–wild-type susceptibility to fluoroquinolones 
was 87.2%. The emergence of isolates with decreased 
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susceptibility to these first-line antimicrobial drugs limits 
effective treatment options for potential human infections.
ESC typing of the 47 isolates, performed by micro-
array analysis followed by PCR and sequencing (online 
Technical Appendix), revealed the presence of the blaCMY-2 
gene in 41 ESC-resistant Salmonella Heidelberg isolates 
that exhibited an AmpC β-lactamase phenotype. The other 
6 isolates exhibited an extended-spectrum β-lactamase 
phenotype and encoded blaCTX-M-2 (n = 4), blaCTX-M-1 (n = 1), 
or blaCTX-M-14 (n = 1) genes (Figure 2).
We assessed the genetic relatedness of the 47 cephalo-
sporin-resistant Salmonella Heidelberg isolates by using the 
standardized XbaI–pulsed-field gel electrophoresis (PFGE) 
(online Technical Appendix), which identified 2 major PFGE 
types: XbaI.1968 and XbaI.1973 (PFGE numbers assigned 
by the European Centre for Disease Prevention and Control, 
Solna, Sweden). Of the 47 isolates, 26 (55.3%) belonged to 
XbaI.1968 and 5 (10.6%) belonged to XbaI.1973. Forty-one 
of the isolates were blaCMY-2 carriers, 31 (75.6%) of which 
belonged to these 2 PFGE types; 10 (24.4%) were distrib-
uted equally among other PFGE types. Six of the 47 isolates 
were blaCTX-M carriers associated with 5 PFGE types (Figure 
2). Comparing these isolates with those in the PulseNet data-
base (http://www.cdc.gov/pulsenet/index.html) revealed the 




Table. Characteristics of Salmonella enterica serovar Heidelberg isolates recovered from human infections, food-producing animals, 
poultry meat, and other sources, the Netherlands, 1999–2013* 
Source 1999–2001 2002–2004 2005–2007 2008–2010 2011–2013 
Human infections      
 No. isolates studied 13 10 22 23 15 
 Resistance  
 phenotypes (no.) 
Amp (1),  
AmpCol (1),  
AmpSmxTmpStr (1), 
AmpTetSmxTmpStr 
(1), SmxStr (1), Str 
(5), TetSmxTmpStr 
(1), WT (2) 
AmpSmxStr (1), 
AmpTetSmx (1), 
SmxStr (3), Str 
(1), TetSmxStr 
(1), WT (3) 
AmpFotTazStr (1), 
AmpSmxTmpNalCip 
(1), AmpTet (1), 
NalCip (2), SmxStr 
(1), Tet (1), 
TetSmxNalCip (1), 
WT (14) 
ChlCol (1), Col (10), 
Str (1), StrCol (5), 
TetCol (1), TetNalCip 
(1), TetSmxTmp 
StrCol (1), TetStr 
KanCol (1), TetStr 
SmxCol (1), WT (1) 
Col (1), Str (3), 
TetSmxStr (2), 
TetSmxTmp (1), WT 
(8) 
 No. ESCR isolates 0 0 1 0 0 
Food-producing animals     
 No. isolates studied 5 16 5 7 13 
 Resistance  
 phenotypes (no.) 






















 No. ESCR isolates 0 0 0 2 5 
Poultry meat      
 No. isolates studied 3 3 15 6 40 
 Resistance  
 phenotypes (no.) 
AmpTetSmxTmpNal
CipStr (1), 

























Col (2), TetSmx 
NalCip (1), TetSmx 
NalCipGenStr (1), 
TetSmxNalCipStr (1) 
 No. ESCR isolates 0 0 0 3 35 
Other      
 No. isolates studied 0 1 0 6 4 
 Resistance  
 phenotypes (no.) 
 WT (1)  Col (2), NalCipCol (1), 
Str (1), StrCol (2) 
AmpFotTazTetSmx 
NalCip (1), 
NalCipCol (1), Str 
(1), TetSmxNal 
CipGenStr (1) 
 No. ESCR isolates 0 0 0 0 1 
*Amp, ampicillin; Cip, ciprofloxacin; Chl, chloramphenicol; Col, colistin; ESCR, extended-spectrum cephalosporin-resistant; Fot, cefotaxime; Gen, 
gentamicin; Kan, kanamycin; Nal, nalidixic acid; Smx, sulfamethoxazole; Str, streptomycin; Taz, ceftazidime; Tet, tetracycline; Tmp, trimethoprim; WT, 
wild type.  
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introduction of 4 epidemic clones of ESC-resistant Salmo-
nella Heidelberg strains in the Netherlands (JF6X01.0022/
XbaI.0251, JF6X01.0326/XbaI.1966, JF6X01.0258/
XbaI.1968, and JF6X01.0045/XbaI.1970). To raise aware-
ness and determine whether related ESC-resistant Salmonel-
la Heidelberg isolates had been observed in other European 
countries, the Epidemic Intelligence Information System 
(European Centre for Disease Prevention and Control) issued 
an alert on September 18, 2014.
We successfully transferred plasmids carrying extend-
ed-spectrum or AmpC β-lactamases from ESC-resistant Sal-
monella Heidelberg isolates to the recipient E. coli DH10B 
strain (online Technical Appendix). PCR-based Inc/Rep typ-
ing and multilocus or double-locus sequence typing (ST) of 
the plasmids revealed that the blaCMY-2 or blaCTX-M genes were 
located on plasmids for 46 (97.8%) of the 47 isolates. ESC-
resistant Salmonella Heidelberg isolates encoding blaCMY-2 
on IncI1/ST12 plasmids were associated predominantly with 
the XbaI.1968 (n = 26 [78.8%]) PFGE type; those encoding 
blaCMY-2 on IncA/C plasmids were associated with XbaI.1973 
(n = 5 [71.4%]). Isolates encoding blaCTX-M-2 on IncHI2P/
ST2, blaCTX-M-1 on IncI1/ST49, and blaCTX-M-14 on IncI1/ST80 
plasmids were associated with XbaI.1964, XbaI.1963, and 
XbaI.1966, respectively (Figure 2).
The blaCMY-2 gene was present in 12 different PFGE 
types and was carried on plasmids of 2 different incom-
patibility groups (IncI1/ST12 and IncA/C) or on the 
chromosome. This gene’s diverse genetic background 
suggests that emergence of the blaCMY-2–producing Salmo-
nella Heidelberg strain in the Netherlands results not only 
from expansion of a single clone but from multiclonal dis-
semination of the strain and horizontal transfer of plas-
mids encoding the blaCMY-2 gene. IncI1/ST12 and IncA/C 
plasmids have been associated with the blaCMY-2 gene in 
Salmonella Heidelberg isolates in the United States and 
Canada (8,15).
We analyzed a subset of ESC-resistant Salmonella 
Heidelberg isolates to determine the size and conjugation 
frequency of plasmids carrying extended-spectrum and 
AmpC β-lactamases. We also assessed a subset of Sal-
monella Heidelberg isolates (n = 17) for each PFGE type, 
including isolates for each type if they showed variation 
in extended-spectrum and AmpC β-lactamase genes or in 
gene location. This assessment sought to detect the up-
stream presence of resistance genes (blaCTX-M and blaCMY) 
of frequently encountered insertion sequences (ISEcp1, 
ISCR1, and IS26) (Figure 2; online Technical Appendix). 
 We attribute the increase of ESC-resistant Salmonella 
Heidelberg isolates in the Netherlands to the frequent oc-
currence of isolates carrying IncI1/ST12 plasmids encod-
ing blaCMY-2 in food-producing animals and poultry prod-
ucts imported from Brazil. Isolates from imported poultry 
products are associated predominantly with PFGE types 
XbaI.1968 and XbaI.1973 (Figure 2). A similar introduction 
of ESC-resistant Salmonella Heidelberg strains in Ireland 
was associated with imported poultry meat from Brazil (R. 
Slowey, pers. comm.). Although ESC-resistant Salmonella 
Heidelberg strains are rarely reported in Europe, their intro-
duction through imported poultry meat could pose a public 
health risk; Brazil is among the world’s leading countries 
for exporting poultry meat.
Conclusions
Most ESC-resistant Salmonella Heidelberg isolates in our 
study had profiles (XbaI.0251, XbaI.1966, XbaI.1968, and 
XbaI.1970) indistinguishable from those of previous epi-
demic types (JF6X01.0022, JF6X01.0326, JF6X01.0258, 
and JF6X01.0045) that caused outbreaks and showed po-
tency for bloodstream infections (16). Our identification 
of clonal clusters shared by ESC-resistant Salmonella 
Heidelberg strains in food-producing animals or poultry 
meat that can cause human infections underscores the risk 
for potential zoonotic or foodborne transmission of these 
strains to humans.
Although we observed a frequent occurrence of ESC-
resistant Salmonella Heidelberg isolates in poultry prod-
ucts, no human infections linked to these contaminated 
products have been yet documented in the Netherlands. 
Nevertheless, the risk of potential zoonotic or foodborne 
transmission of ESC-resistant Salmonella Heidelberg 
strains highlights the necessity for active surveillance and 
intervention strategies by public health organizations.
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Figure 1. Occurrence of extended-spectrum cephalosporin-
resistant Salmonella enterica serovar Heidelberg isolates, the 
Netherlands, 1999–2013. 
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